Resultado de búsqueda
15 de may. de 2023 · Abstract. Stenotrophomonas maltophilia (SM) represents a challenging pathogen due to its resistance profile. A systematic review of the available evidence was conducted to evaluate the best treatment of SM infections to date, focusing on trimethoprim/sulfamethoxazole (TMP/SMX), fluoroquinolones (FQs), and tetracycline derivatives (TDs).
- Antimicrobial Treatment Strategies for Stenotrophomonas ...
In one retrospective review of 284 patients, the 30-day...
- Stenotrophomonas Maltophilia - StatPearls - NCBI Bookshelf
Objectives: Review the risk factors for developing...
- Antimicrobial Treatment Strategies for Stenotrophomonas ...
Infections of S. maltophilia can occur in a range of organs and tissues; the organism is commonly found in respiratory tract infections. This review summarizes the current literature and presents S. maltophilia as an organism with various molecular mechanisms used for colonization and infection.
Stenotrophomonas maltophilia is an opportunistic pathogen of significant concern to susceptible patient populations. This pathogen can cause nosocomial and community-acquired respiratory and bloodstream infections and various other infections in humans. Sources include water, plant rhizospheres, animals, and foods.
Abstract. Stenotrophomonas maltophilia is a Gram-negative opportunistic pathogen that can cause many infections, such as chronic pulmonary infections in patients with cystic fibrosis and infections in immunocompromised patients with hematology–oncol-ogy diseases.
5 de may. de 2022 · Stenotrophomonas maltophilia is an environmental Gram-negative bacillus that has emerged as a cause of a variety of clinical syndromes, mainly pulmonary and bloodstream infections (BSIs). 1–3 S. maltophilia primarily impacts vulnerable populations, such as patients with cystic fibrosis (CF), cancer and other conditions leading to an immunosuppre...
